highly significantp < 0.05
Pharmacokinetic Study A validated HPLC method was successfully applied to characterize the comprehensive pharmacokinetic profile of trans -RES in rat plasma following administration via five different routes, as shown in Figure and revealed highly significant differences ( p < 0.05) in the disposition profile of the compound among the evaluated administration routes, as demonstrated by Tukey’s posthoc test results Table .